Comparative Study between Quantitative Digital Image Analysis and Fluorescence In Situ Hybridization of Breast Cancer Equivocal HER2 2+Cases

被引:0
|
作者
Ayad, E. [1 ]
Mansy, M. [1 ]
Elwi, D. [1 ]
Salem, M. [1 ]
Salama, M. [2 ,3 ]
Kayser, K. [4 ]
机构
[1] Cairo Univ, Dept Pathol, Fac Med, Cairo, Egypt
[2] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[3] ARUP Reference Lab, Salt Lake City, UT USA
[4] Humboldt Univ, Dept Pathol, D-10099 Berlin, Germany
关键词
D O I
10.1155/2014/608254
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [42] A comparative study of immunohistochemical and chromogenic in situ hybridization (CISH) evaluation of HER2 status in breast cancer
    Lubomirova, Hristova S.
    Vlahova, I. A.
    Iliichev, Dikov T.
    VIRCHOWS ARCHIV, 2009, 455 : 192 - 192
  • [43] Equivocal cases of Her-2 gene amplification detected by fluorescence in situ hybridization.
    Espinoza, FP
    Yang, X
    Reddy, KS
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 76 - 76
  • [44] Concordance between immunohistochemistry and fluorescence in situ hybridization for assessment of the HER2
    Cho, S. H.
    Lee, M. R.
    Kim, D. C.
    Lee, K. C.
    Lee, J. H.
    Kwon, H. C.
    Lee, H. S.
    Lee, S.
    BREAST, 2011, 20 : S21 - S21
  • [45] Automated Quantitative RNA In Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma
    Wang, Z.
    Portier, B. P.
    Gruver, A. M.
    Bui, S.
    Wang, H.
    Su, N.
    Vo, H-T
    Ma, X-J
    Luo, Y.
    Budd, G. T.
    Tubbs, R. R.
    CANCER RESEARCH, 2012, 72
  • [46] Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma
    Wang, Zhen
    Portier, Bryce P.
    Gruver, Aaron M.
    Bui, Son
    Wang, Hongwei
    Su, Nan
    Vo, Hong-Thuy
    Ma, Xiao-Jun
    Luo, Yuting
    Budd, G. Thomas
    Tubbs, Raymond R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (02): : 210 - 219
  • [47] Comparison between Fluorescence In Situ Hybridization (FISH) and Dual In Situ Hybridization (DISH) in the determination of HER2 status in breast cancer among Filipinos
    Espiritu, G. A.
    dela Fuente, E.
    Diwa, M.
    VIRCHOWS ARCHIV, 2019, 475 : S98 - S98
  • [48] The Correlation Between Dual-color Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization in Assessing HER2 Gene Amplification in Breast Cancer
    Pedersen, Marianne
    Rasmussen, Birgitte Bruun
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2009, 18 (02) : 96 - 102
  • [49] HER2 Testing for Breast Cancer in the Genomics Laboratory A Sea Change for Fluorescence In Situ Hybridization
    Geiersbach, Katherine B.
    Sill, Daniel R.
    Meyer, Reid G.
    Yuhas, Jason A.
    Sukov, William R.
    Mounajjed, Taofic
    Carter, Jodi M.
    Jenkins, Robert B.
    Chen, Beiyun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (07) : 883 - 886
  • [50] Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer
    Furrer, Daniela
    Jacob, Simon
    Caron, Chantal
    Sanschagrin, Francois
    Provencher, Louise
    Diorio, Caroline
    ANTICANCER RESEARCH, 2017, 37 (06) : 3323 - 3329